In last trading session, Cellectar Biosciences Inc (NASDAQ:CLRB) saw 1.21 million shares changing hands with its beta currently measuring 1.01. Company’s recent per share price level of $0.33 trading at $0.02 or 5.38% at ring of the bell on the day assigns it a market valuation of $15.25M. That closing price of CLRB’s stock is at a discount of -1248.48% from its 52-week high price of $4.45 and is indicating a premium of 33.33% from its 52-week low price of $0.22.

For Cellectar Biosciences Inc (CLRB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.35 in the current quarter.

Cellectar Biosciences Inc (NASDAQ:CLRB) trade information

Upright in the green during last session for gaining 5.38%, in the last five days CLRB remained trading in the green while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $0.33 price level, adding 5.44% to its value on the day. Cellectar Biosciences Inc’s shares saw a change of 10.70% in year-to-date performance and have moved 14.93% in past 5-day. Cellectar Biosciences Inc (NASDAQ:CLRB) showed a performance of 35.93% in past 30-days.

Wall Street analysts have assigned a consensus price target of 12 to the stock, which implies a rise of 97.25% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 12. It follows that stock’s current price would drop -3536.36% in reaching the projected high whereas dropping to the targeted low would mean a loss of -3536.36% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 41.77% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 48.15% while estimates for its earnings growth in next 5 years are of 32.07%.